Literature DB >> 3996461

Low-dose heparin in experimental peritonitis.

S Gupta, P K Jain.   

Abstract

The aim of this investigation was to study the beneficial role of low-dose heparin in peritonitis. Peritonitis was induced in 20 dogs by the technique of Rosato and co-authors, 10 of which received low-dose heparin subcutaneously for 5 days in a dose of 100 units/kg body weight. Decreased mortality as well as decrease in the formation of intra-abdominal abscesses and adhesions were observed in the heparin-treated dogs. Some of the possible underlying mechanisms for beneficial effects of heparin in peritonitis are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3996461     DOI: 10.1159/000128463

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  4 in total

1.  Mesenteric thrombus associated with pulmonary, splenic, portal, and caval thrombi in a dog that was presented for an acute abdomen.

Authors:  Adam Joseph Rudinsky; Valerie Jill Parker; Julien Guillaumin
Journal:  Can Vet J       Date:  2016-10       Impact factor: 1.008

2.  Comparing Lavage of the Peritoneal Cavity with Lidocaine, Bupivacaine and Normal Saline to Reduce the Formation of Abdominal Adhesion Bands in Rats.

Authors:  Hossein Parsa; Hengameh Saravani; Fatemeh Sameei-Rad; Marjan Nasiri; Zahra Farahaninik; Amirhossein Rahmani
Journal:  Malays J Med Sci       Date:  2017-06-30

Review 3.  The effect of heparin administration in animal models of sepsis: a prospective study in Escherichia coli-challenged mice and a systematic review and metaregression analysis of published studies.

Authors:  Yan Li; Jun-Feng Sun; Xizhong Cui; Haresh Mani; Robert L Danner; Xuemei Li; Jun-Wu Su; Yvonne Fitz; Peter Q Eichacker
Journal:  Crit Care Med       Date:  2011-05       Impact factor: 7.598

4.  The effectiveness of local anesthetics in preventing postoperative adhesions in rat models.

Authors:  E Ozturk; A Yilmazlar; S Berhuni; T Yilmazlar
Journal:  Tech Coloproctol       Date:  2010-10-08       Impact factor: 3.781

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.